The coordinated management of ribosome and translation during injury and regeneration
Student11:48CCAI
paperi.ai
0:00 / 0:00
Thanh Nguyen, Jason C. Mills, Charles J. Cho
After injury, cells do not simply switch translation on or off. The ribosome itself is remodeled, degraded, and linked to p53 and cell-cycle decisions—putting this familiar protein factory at the center of regeneration.
Diverse acute and chronic injuries induce damage responses in the gastrointestinal (GI) system, and numerous cell types in the gastrointestinal tract demonstrate remarkable resilience, adaptability, and regenerative capacity in response to stress. Metaplasias, such as columnar and secretory cell metaplasia, are well-known adaptations that these cells make, the majority of which are epidemiologically associated with an elevated cancer risk. On a number of fronts, it is now being investigated how cells respond to injury at the tissue level, where diverse cell types that differ in proliferation capacity and differentiation state cooperate and compete with one another to participate in regeneration. In addition, the cascades or series of molecular responses that cells show are just beginning to be understood. Notably, the ribosome, a ribonucleoprotein complex that is essential for translation on the endoplasmic reticulum (ER) and in the cytoplasm, is recognized as the central organelle during this process. The highly regulated management of ribosomes as key translational machinery, and their platform, rough endoplasmic reticulum, are not only essential for maintaining differentiated cell identity, but also for achieving successful cell regeneration after injury. This review will cover in depth how ribosomes, the endoplasmic reticulum, and translation are regulated and managed in response to injury (e.g., paligenosis), as well as why this is essential for the proper adaptation of a cell to stress. For this, we will first discuss how multiple gastrointestinal organs respond to stress through metaplasia. Next, we will cover how ribosomes are generated, maintained, and degraded, in addition to the factors that govern translation. Finally, we will investigate how ribosomes and translation machinery are dynamically regulated in response to injury. Our increased understanding of this overlooked cell fate decision mechanism will facilitate the discovery of novel therapeutic targets for gastrointestinal tract tumors, focusing on ribosomes and translation machinery.
Transcript
After injury, cells do not simply switch translation on or off. The ribosome itself is remodeled, degraded, and linked to p53 and cell-cycle decisions—putting this familiar protein factory at the center of regeneration. Diverse acute and chronic injuries induce damage responses in the gastrointestinal system, while numerous gastrointestinal cell types show resilience, adaptability, and regenerative capacity in response to stress.
Metaplasias, including columnar and secretory cell metaplasia, are well-known adaptations, and most are epidemiologically associated with an elevated cancer risk. The ribosome is a ribonucleoprotein complex essential for translation on the endoplasmic reticulum and in the cytoplasm, and it is recognized as the central organelle during this process.
The highly regulated management of ribosomes and their rough endoplasmic reticulum platform is essential both for maintaining differentiated cell identity and for successful cell regeneration after injury. Metaplasia is the transformation of one type of cell into another type of cell that did not exist in that tissue at homeostasis, and metaplasias are recognized indicators of chronic inflammation and increased cancer risk.
In the stomach, goblet cells are called intestinal metaplasia and indicate longstanding H. pylori infection and an elevated risk of gastric cancer. In the esophagus, goblet cells and transition from squamous epithelium to columnar epithelium are known as Barrett’s esophagus and are a precursor to esophageal cancer.
Stomach chief cells can undergo spasmolytic polypeptide-expressing metaplasia, or SPEM, expressing Trefoil factor 2 and pepsinogen after injuries such as H. pylori infection. Pancreatic acinar cells can undergo acinar-to-ductal metaplasia, or ADM, which can ultimately progress to pancreatic ductal adenocarcinoma through pancreatic intraepithelial neoplasia.
The response of secretory cells to injury occurs through an evolutionarily conserved, stepwise process called paligenosis. Paligenosis consists of three sequential stages: autophagic-lysosomal degradation of organelles, induction of metaplastic and embryonic genes, and re-entry into the cell cycle.
Understanding these cell-intrinsic changes provides a window into how differentiated gastrointestinal cells respond to injury, become metaplastic, regenerate, and may become carcinogenic during the process. Despite progress in understanding paligenosis, the ribosome remains a component crucial in determining cell fate during injury that is still insufficiently understood.
The generation and maintenance of adequate numbers of ribosomes are essential for their primary function of translation. The review focuses on ribosomal behaviors that have been understudied but are found in diverse cell types upon injury. It highlights how understanding these ribosomes can inform views of digestive tract plasticity.
Figure one maps ribosome production and use during cellular homeostasis. In the nucleolus, RNA polymerase one transcribes ribosomal DNA into eighteen S, five point eight S, and twenty-eight S ribosomal RNA, while other polymerases produce five S RNA, transfer RNAs, messenger RNAs, and translation factors.
The resulting forty S and sixty S subunits assemble into monosomes, which can form polysomes in the cytosol or, with signal recognition particle guidance, translate messages on the endoplasmic reticulum. A ribosome is an evolutionarily conserved ribonucleoprotein complex that is indispensable for translation.
Ribosomes exist in the cytoplasm or on the rough endoplasmic reticulum, where nascent polypeptides undergo extensive modification to be secreted or membrane-bound. De novo ribosome biogenesis begins in the nucleolus, a membrane-less structure in the nucleus.
The nucleolus has three subcompartments: the fibrillary center, the dense fibrillary component, and the granular component, where ribosomal RNAs mature and specific nucleolar proteins are localized. Translation of messenger RNA is the primary function of the ribosome, and formation of a ternary complex in the cytosol initiates the translation process.
With GTP as an energy source, the eIF2 complex binds to methionyl transfer RNA and forms a forty-three-S preinitiation complex with the forty-S small subunit and initiation factors eIF1, eIF1A, and eIF3. Messenger RNA is activated by the eIF4 complex and poly-A-binding protein, while eIF4G allows a closed-loop structure composed of the eIF4F complex, messenger RNA, and poly-A-binding protein.
The preinitiation complex scans the five-prime untranslated region to identify the start codon, then eIF5B catalyzes joining of the large subunit to form the eighty-S ribosome. Cells must continuously monitor and maintain the optimal number of ribosomes according to their translation needs and energy expenditure costs.
This balance is maintained by multiple sensors and executors, including key signaling pathways that maintain the equilibrium. mTORC1, Myc, and AMPK play significant roles in regulating ribosome biogenesis, although no factor is solely responsible for governing the pathway.
The initial response of injured cells is to decrease biogenesis of nascent ribosomes and shut down translation, lessening workload and energy consumption. The rough endoplasmic reticulum also experiences functional or structural changes.
Existing cytosolic and rough endoplasmic reticulum ribosomes undergo autophagy, known respectively as ribophagy and reticulophagy. Perturbation of ribosome biogenesis and disruption of ribosome homeostasis result in p53 stabilization in a manner similar to ribosomopathy.
Ribosome biogenesis is further blocked at the processing step, and during stress pre-ribosomal RNA processing ceases at a relatively early stage of processing. Suppression of mTORC1 reduces phosphorylation of four-E-binding protein one, strengthening its association with eIF4E and limiting translation initiation, particularly for transcripts containing five-prime TOP motifs.
Unphosphorylated LARP1 interacts with the five-prime and three-prime untranslated regions of ribosomal protein messenger RNAs, while mTORC1 and Akt phosphorylation of LARP1 promotes ribosomal protein translation. During stress, a decrease in mTORC1 can therefore result in decreased ribosomal protein levels and a subsequent decrease in the number of ribosomes.
Global synthesis blocking occurs directly at translation, involving stalling or blocking at the initiation step, a rate-limiting step of translation. The best-known stress-induced mechanism is serine fifty-one phosphorylation on the alpha subunit of eIF2, mediated by GCN2, PKR, PERK, and HRI.
This phosphorylation arrests translation by changing affinity for eIF2B, the guanidine exchange factor that recharges eIF2 with GTP and is critical for initiating another round of translation. Figure two maps several ribosome responses to injury, including reduced translation, protective ribosome-plugging proteins, and autophagic removal through ribophagy and reticulophagy.
The visible panels emphasize that cytosolic and rough-ER ribosomes can be degraded, while ribosomal proteins and the five-S ribosomal RNA complex can sequester MDM2, stabilize p53, and lead to cell-cycle blockage. This matters because ribosome regulation links energy conservation and protein-quality control to stress-induced decisions about cell proliferation.
Reducing the absolute amount of existing translation machinery, meaning ribosomes, is another strategy for reducing translation workload and energy expenditure. Because ribosomes are free-floating in the cytosol or attached to the endoplasmic reticulum, degradation can occur through ribophagy or through autophagy of the rough endoplasmic reticulum, called reticulophagy.
In yeast, nitrogen deficiency induces selective ribophagy through the Ubp3p and Bre5p ubiquitin protease complex. Fasting or mTORC1 suppression induces selective ribophagy, with NUFIP1 interacting with both ribosomes and LC3B as a specialized receptor. Ribosomes are crucial mediators of p53 stabilization during the injury response.
Mutations or reduced expression in ribosomal proteins or ribosome-biogenesis factors cause developmental defects called ribosomopathies, which are associated with p53 stabilization. Diamond-Blackfan anemia involves mutations in genes coding for ribosomal proteins such as RPS19, RPS24, RPL5, or RPL11, and its effects can at least partially be corrected by deletion of p53.
Treacher-Collins syndrome causes deficient ribosome synthesis and p53-dependent apoptosis in embryonic neural crest cells, leading to craniofacial birth defects that can be rescued by knocking out p53. The phase during which p53 serves as a key checkpoint demonstrates a close relationship between ribosome integrity, p53, and proliferation after injury in vivo.
The ribosome may link perturbation of major signaling pathways such as mTORC1 or Myc with cell-cycle progression and p53 stabilization during injury. Ribosomes are regulated in a distinct and specific manner during injury, and this regulation is crucial for cells to cope with injury and regenerate.
This understanding transforms ribosomes from passive translational machinery into essential injury responders and cell fate determinants. It brings stress granule formation, translational block, ribosome plugging, autophagy, p53 stabilization, cell death, and cell-cycle re-entry together with the ribosome and endoplasmic reticulum at the center.
Important questions remain, including whether ribosome number and function differ significantly by cell type and how ribosome and endoplasmic reticulum remodeling or destruction alters translational profiles. The review’s central message is that ribosomes are active injury responders and cell fate determinants, coordinating translation, autophagy, p53 stabilization, and regeneration while also raising important questions for tumor biology.
A derivative work by Paperi · AI-generated script, voice and captions
· pages and figures unaltered
Made with Paperi.
Drop in a research PDF — get a narrated video walkthrough like this one,
with highlights that follow the narration. Free to start.
Filippo Calascibetta, Annalisa Martorana, Margot Lo Pinto, Claudia Carcione, Salvatore D’Arpa, Giandomenico Amico, Vitale Miceli, Nicola Cuscino, Gioacchin Iannolo, L. Volpe, Simone Dario Scilabra, Pier Giulio Conaldi, Cinzia Maria Chinnici
Tiny packages released by human cells can help calm the process that scars a liver. But before such treatments reach patients, scientists need a way to make those packages cleanly and consistently.What if the culture medium used to grow therapeutic cells quietly changes the quality of the vesicles they release? This study tests whether a GMP-compliant, serum-free medium can make production more standardized without sacrificing anti-fibrotic activity.
Jianfeng Sun, Jinlong Ru, Lorenzo Ramos‐Mucci, Fei Qi, Zihao Chen, Suyuan Chen, Adam P. Cribbs, Li Deng, Xia Wang
A drug may affect a tiny genetic message by turning its activity up or down—but finding out which direction it takes can require slow, expensive experiments. This study asks whether a computer can make that prediction first.A drug may bind a microRNA, but binding alone does not tell you whether that microRNA goes up or down. DeepsmirUD tackles that missing direction using an ensemble of twelve deep-learning frameworks.
A traditional herbal root contains a valued protective compound, but only a small amount is normally available. This study found that growing a food fungus on the root could make much more of that compound accessible after digestion.A medicinal fungus turns a hard-to-access Astragalus compound into something far more abundant—and the fermented material still shows stronger antioxidant activity after simulated digestion.